Phospho-Akt overexpression in non-small cell lung cancer confers significant stage-independent survival disadvantage.
David
Odile
O
Department of Pathology, Tulane University School of Medicine, New Orleans, LA 70112, USA. odavid@tulane.edu
LeBeau
Helena
H
Brody
Arnold R
AR
Friedman
Mitchell
M
Jett
James
J
D002289:Carcinoma, Non-Small-Cell Lung / Q000737:chemistry* / Q000401:mortality* / Q000473:pathology; D005500:Follow-Up Studies; D006801:Humans; D019394:Ki-67 Antigen / Q000032:analysis; D008175:Lung Neoplasms / Q000737:chemistry* / Q000401:mortality* / Q000473:pathology; D009363:Neoplasm Proteins / Q000032:analysis*; D011379:Prognosis; D017346:Protein Serine-Threonine Kinases / Q000032:analysis*; D011518:Proto-Oncogene Proteins / Q000032:analysis*; D051057:Proto-Oncogene Proteins c-akt; D016159:Tumor Suppressor Protein p53 / Q000032:analysis
D019394:Ki-67 Antigen; D009363:Neoplasm Proteins; D011518:Proto-Oncogene Proteins; D016159:Tumor Suppressor Protein p53; C494918:AKT1 protein, human; D017346:Protein Serine-Threonine Kinases; D051057:Proto-Oncogene Proteins c-akt